Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Zhu, Meidong [1 ,2 ]
Chang, Andrew Alexander [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4965
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    [J]. OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
  • [2] INTRAVITREAL AFLIBERCEPT FOR TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS: 3-YEAR OUTCOMES IN SUBFOVEAL CENTRAL CHOROID THICKNESS
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    Chang, Andrew A.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 125 - 125
  • [3] INTRAVITREAL AFLIBERCEPT FOR TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 52 - 52
  • [4] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 2-year Outcomes
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Joachim, Nichole
    Wong, Lily
    Zhu, Meidong
    Chang, Andrew Alexander
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Gharbiya, Magda
    Iannetti, Ludovico
    Parisi, Francesco
    De Vico, Umberto
    Mungo, Maria Laura
    Marenco, Marco
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [6] One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Li, Xun
    Zhang, Yun
    Zhang, Zirong
    Xu, Yunyi
    Zhang, Meixia
    [J]. OPHTHALMIC RESEARCH, 2019, 62 (02) : 93 - 100
  • [7] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes
    Chang, Andrew A.
    Broadhead, Geoffrey K.
    Hong, Thomas
    Joachim, Nichole
    Syed, Adil
    Schlub, Timothy E.
    Toth, Levente
    Peto, Tunde
    Zhu, Meidong
    [J]. OPHTHALMIC RESEARCH, 2016, 55 (02) : 84 - 90
  • [8] Retinal Morphology Changes Following Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Broadhead, Geoffrey
    Hong, Thomas
    Li, Haitao
    Zhu, Meidong
    Wijeyakumar, Wijeyanthy
    Chang, Andrew Alexander
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] RESPONSE OF PIGMENT EPITHELIAL DETACHMENTS TO INTRAVITREAL AFLIBERCEPT AMONG PATIENTS WITH TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Broadhead, Geoffrey K.
    Hong, Thomas
    Zhu, Meidong
    Li, Haitao
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Chang, Andrew A.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (05): : 975 - 981
  • [10] Morphological changes with Intravitreal Aflibercept for Treatment Resistant Neovascular Age-Related Macular Degeneration
    Wong, Lily
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Zhu, Meidong
    Chang, Andrew Alexander
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345